Bacterial postbiotics as promising tools to mitigate cardiometabolic diseases
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases
Final published version, 2.62 MB, PDF document
Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.
| Original language | English |
|---|---|
| Journal | Journal of Lipid and Atherosclerosis |
| Volume | 10 |
| Issue number | 2 |
| Pages (from-to) | 123-129 |
| Number of pages | 7 |
| ISSN | 2287-2892 |
| DOIs | |
| Publication status | Published - 2021 |
Bibliographical note
Publisher Copyright:
© 2021 The Korean Society of Lipid and Atherosclerosis.
- Akkermansia, Diabetes mellitus, type 2, Lipopolysaccharides, Obesity, Peptidoglycan
Research areas
ID: 285449134